Mar 17 • General discussion
All Peptide Vendors That Shut Down in 2025–2026
What Happened to the Research Peptide Industry?
The research peptide industry has gone through one of the most dramatic shake-ups in its history between 2025 and 2026.
Multiple well-known research chemical and peptide vendors have either shut down, disappeared, or been forced offline, leaving researchers scrambling to find reliable suppliers.
The biggest shock came in March 2026, when one of the most recognizable vendors in the industry suddenly closed its doors.
That vendor was Peptide Sciences.
This article breaks down:
- The major peptide vendors that shut down
- Why the industry is under pressure
- Which vendors could still be at risk
- How new suppliers like Orion Peptides are attempting to fill the gap
The Biggest Shutdown: Peptide Sciences (2026)
Peptide Sciences was widely considered the most recognizable grey-market peptide supplier in the United States.
For years, the company sold research peptides such as:
- BPC-157
- TB-500
- CJC-1295
- PT-141
- GLP-1 analogs like semaglutide and tirzepatide
In March 2026, the company suddenly posted a notice that it had voluntarily shut down operations and discontinued all research products.
Shortly after:
- The website stopped accepting orders
- Customer accounts disappeared
- No further support or updates were provided
For a company that had become one of the most trusted names in the space, the shutdown was a major shock to the research community.
Industry analysts believe the closure was not caused by a single event but by multiple pressures converging at once.
Other Peptide Vendors That Shut Down
Peptide Sciences was not the only vendor to disappear. Several other companies exited the market between 2025 and early 2026.
Science.bio was one of the most respected research chemical suppliers in the industry.
In January 2026, the company shut down operations without providing a detailed public explanation.
Science.bio had previously been known for:
- High-purity research chemicals
- Transparent testing documentation
- A strong reputation in the biohacking community
Its shutdown removed one of the most technically respected suppliers from the market.
Amino Asylum
Amino Asylum was another well-known vendor that reportedly went offline after regulatory enforcement actions.
Reports indicate the company’s warehouse was raided and operations ceased in 2025, removing one of the larger budget peptide suppliers from the market.
Vendors That Received FDA Warnings
Several other suppliers have not fully shut down but received warning letters from regulators, including:
- Prime Peptides
- Xcel Peptides
- SwissChems
- Summit Research
- PureRawz
These warnings often focus on marketing peptides as “research chemicals” while they are widely used for human performance or medical purposes, which regulators classify as selling unapproved drugs.
For many vendors, warning letters are the first step before shutdowns.
Why Peptide Vendors Are Shutting Down
There are three major forces reshaping the peptide industry.
1. FDA Enforcement Has Increased
The biggest reason vendors are disappearing is regulatory pressure.
Agencies such as the FDA and Department of Justice have increased enforcement against companies selling peptides labeled “research use only” while being marketed to consumers.
The regulatory position is clear:
Peptides sold directly to consumers without approval are considered unapproved pharmaceutical drugs.
As a result, many companies chose to close voluntarily before facing enforcement actions.
2. Pharmaceutical Legal Pressure
Large pharmaceutical companies have also begun protecting their blockbuster drugs.
For example:
- Legal action was filed against vendors selling tirzepatide
- Import bans were placed on infringing products
These legal battles make it extremely risky for peptide vendors to sell compounds related to major pharmaceutical drugs.
3. Quality and Testing Problems
Independent testing organizations have also uncovered major quality inconsistencies across peptide vendors.
Some peptides from certain vendors tested accurately, while others showed:
- incorrect peptide concentration
- contamination
- counterfeit compounds
These issues increased scrutiny on the entire industry and damaged trust.
Vendors That May Still Be At Risk
Because of regulatory pressure, any grey-market peptide vendor operating today carries some risk.
Common warning signs include:
- No third-party testing
- Lack of batch COAs
- Selling GLP-1 drugs without prescription oversight
- Aggressive health claims
The reality is that the old grey-market peptide model is rapidly disappearing.
Many vendors will either:
- move toward more transparent research standards
- relocate operations internationally
- or shut down entirely.
The Gap Left Behind by Peptide Sciences
When Peptide Sciences shut down, it left a massive gap in the market.
The company had become a default supplier for thousands of researchers worldwide. When it disappeared overnight, many laboratories and independent researchers had to rethink their sourcing strategies.
One of the biggest risks after a major shutdown is the rise of scam vendors pretending to replace trusted suppliers.
The Rise of “Overnight” Vendors
Whenever a major supplier disappears, opportunistic actors often move quickly to take advantage of the confusion.
Since the shutdown of Peptide Sciences, several overnight vendors have appeared attempting to imitate the Peptide Sciences brand, including:
- Copycat website designs
- Similar product catalogs
- Domains that look almost identical to the original site
- Fake “relaunch” claims pretending to be the original company
Some of these sites are designed specifically to trick former Peptide Sciences customers into placing orders, even though they have no connection to the original company.
In many cases, these websites:
- Launch within days of a shutdown
- Have no verified history or community presence
- Lack legitimate testing documentation
- Disappear just as quickly as they appeared
Because of this, researchers should be extremely cautious when encountering new vendors that appear suddenly and attempt to mimic previously trusted brands.
Stick With Vendors That Have Community Trust
A safer approach is to stick with vendors that have:
- An active online community discussing them
- Verified customer feedback
- Transparent documentation and COAs
- A track record of consistent operations
Trusted suppliers tend to build reputations over months or years, not overnight.
The peptide industry is currently going through a period of transition, and while new suppliers will inevitably emerge, researchers should prioritize transparency and community trust above all else.
A New Vendor Filling the Void: Orion Peptides
Orion Peptides is one of the newer suppliers that has emerged as the industry evolves.
Unlike many earlier vendors, Orion has built its reputation around transparency and research-focused standards.
Some characteristics researchers often look for include:
- Certificates of Analysis (COAs) for products
- Research-only labeling
- Clear product documentation
- Consistent product availability
Because the peptide landscape is changing quickly, many researchers now prioritize vendors that openly publish testing data and documentation.
Full Transparency
Whenever a vendor is recommended, transparency is essential.
If you are researching suppliers, Orion Peptides is one option worth evaluating.
You can explore their research catalog here:
They also offer a 10% discount with code: Peptide10
As with any supplier in this space, researchers should always:
- review testing documentation
- verify certificates of analysis
- conduct independent due diligence
Final Thoughts
The peptide industry is entering a new phase.
Between 2025 and 2026, several major suppliers disappeared, including:
- Peptide Sciences
- Science.bio
- Amino Asylum
These shutdowns were driven by regulatory pressure, legal challenges, and quality concerns.
But peptides themselves are not disappearing.
Instead, the industry is shifting toward:
- more transparent suppliers
- regulated medical channels
- higher quality standards
For researchers, the key takeaway is simple:
Choose suppliers carefully and prioritize transparency above all else.
Disclaimer:
The information presented in this article is provided for educational and informational purposes only. The compounds discussed are research chemicals and peptides intended strictly for laboratory and scientific research use. They are not approved for human consumption by the U.S. Food and Drug Administration (FDA) or other regulatory authorities unless explicitly stated otherwise.
This article does not constitute medical advice, legal advice, or recommendations for personal use of any compound mentioned. Researchers and readers are responsible for conducting their own independent due diligence and complying with all applicable laws and regulations in their jurisdiction.
Any vendors mentioned are referenced for informational transparency only, and inclusion does not guarantee product quality, safety, or regulatory compliance. The peptide industry is rapidly evolving, and availability, legality, and regulatory status may change.
Always consult qualified professionals and regulatory guidance when conducting scientific research involving peptides or related compounds.
0
0 comments
All Peptide Vendors That Shut Down in 2025–2026
powered by
skool.com/biohacking-and-longevity-group-3757
All-in-one peptide education community. 🧪
Dosing guides, storage protocols, stacking frameworks, vendor intel, GLP-1 research, and expert support.🧬
Suggested communities
Powered by